Thursday, Sep 16, 1982

Geneticist Martin To Join Genentech as Vice President of Research

South San Francisco, Calif. -- September 16, 1982 --

Dr. David William Martin, Jr., an eminent physician and geneticist, will join Genentech in January, 1983, as Vice President, Research. Martin, 41, currently holds professorships in both medicine and biochemistry at the University of California, San Francisco(UCSF).

"David Martin has compiled a long and impressive record of accomplishments in biomedical research and will be a strong addition to our management team," says Genentech's President Robert A. Swanson. "His seasoned direction of Genentech's research division, which has pioneered many of the scientific advances in genetic engineering, should ensure that we will remain the pacesetter in genetic engineering research. Dr. Martin brings to Genentech not only the insights of a high caliber biochemist, but also a thorough understanding of medical needs arriving from his clinical experience."

Martin has conducted biomedical research for almost 20 years, the last 13 of which he has spent at UCSF. His principal research interest is in the molecular biology and genetics of mammalian cells, and he has published over 70 scientific papers.

He is also currently serving as UCSF's Chief of Medical Genetics Service, is a member of the Recombinant DNA Advisory Committee of the National Institutes of Health, and is the senior author of a standard textbook of biochemistry, which is published in 12 languages.

After two years of undergraduate work at the Massachusetts Institute of Technology, Martin entered the medical school of Duke University, where he began his research career and from which he earned his M.D. degree in 1964. After completing a clinical residency at Duke, Martin worked in the Laboratory of Molecular Biology at the National Institute of Arthritis and Metabolic Diseases for three years. He joined the faculty of UCSF in 1969.

Genentech, Inc., headquartered in South San Francisco, is a leading genetic engineering company, which is developing products for pharmaceutical, agricultural and industrial chemical applications.

# # #